Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO

Group 1 - Soleno Therapeutics, Inc. is facing a class action lawsuit for securities law violations related to misleading statements about its drug candidate DCCR [1] - The class period for the lawsuit is from March 26, 2025, to November 4, 2025, with a deadline for participation set for May 5, 2026 [1] - The lawsuit claims that Soleno downplayed safety concerns revealed in its Phase 3 clinical trial, leading to false and materially misleading public statements [1]